In short
Overview
A raised haematocrit on testosterone replacement therapy (TRT) is a signal to review the treatment, not only the number. Dr. Felix Lucian Happich reviews the result, the trend and the prescription in Dubai.
Direct Answer
A high haematocrit on TRT means testosterone has increased red blood cell production; a haematocrit of 54 percent or more stops treatment until it falls. Haematocrit is the share of blood volume made up of red blood cells. Erythrocytosis, a haematocrit above 54 percent or haemoglobin above 17.5 g/dL, raises the risk of blood clots. Clinical guidance lowers the dose or pauses treatment when haematocrit rises above the upper normal limit, rechecks it about 2 months later and restarts at a lower dose when it has normalised.
Who This Applies To
This article is for men on testosterone whose blood count has been flagged as high. The full monitoring schedule for TRT is on the testosterone replacement therapy page.
Option Comparison / Decision Criteria
The response depends on the level and the circumstances. The table lists the usual thresholds.
| Finding | Usual response |
|---|---|
| Haematocrit above 50 percent before treatment | Cause investigated and treated before testosterone starts |
| Above the upper normal limit during treatment | Lower dose or pause; repeat after about 2 months |
| 54 percent or more | Treatment stopped; restart at a lower dose once normal |
| High despite low-normal testosterone | Assessment for low oxygen levels and sleep apnoea |
Erythrocytosis is more frequent with injected testosterone esters at high doses and rare with gels dosed to keep testosterone in the normal range, as in the Testosterone Trials and the TRAVERSE trial.
Why an In-Person Physician Review Matters
A review links the haematocrit to the preparation, the dose, the timing of the last injection and possible other causes, such as sleep apnoea.
Lowering the dose, or changing to a gel, reduces the peaks above the normal range that drive erythrocytosis. A raised haematocrit that persists at a low-normal testosterone points to another cause that needs its own assessment.
Frequently Asked Questions
A haematocrit of 54 percent or more stops testosterone treatment until it normalises. A value above the upper normal limit leads to a lower dose or a pause and a repeat test after about 2 months.
A high haematocrit does not usually end TRT permanently. Treatment restarts at a lower dose once the haematocrit is normal, often with a preparation that gives steadier levels.
Haematocrit is checked 3 to 6 months after starting testosterone and then yearly, and again about 2 months after any dose reduction or pause.
Injected testosterone esters at high doses produce peaks above the normal range, and erythrocytosis is more common with them than with gels dosed to keep testosterone in the normal range.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline
- Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE)
- Effects of Testosterone Treatment in Older Men (The Testosterone Trials)
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.